Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
KELA_DIAB_INSUL
Extra metadata
List of similar endpoints to
Diabetes, insuline treatment (Kela reimbursement)
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 35490 | 16070 | 19420 |
| Unadjusted prevalence (%) | 13.65 | 10.94 | 17.17 |
| Mean age at first event (years) | 53.74 | 52.90 | 54.43 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.03 | 2.29 [2.06, 2.54] | 2.3e-54 | 3787 |
| 15 years | 0.01 | 2.14 [1.95, 2.35] | 3.9e-60 | 2832 |
| 5 years | 0.00 | 2.39 [2.15, 2.66] | 2.1e-59 | 877 |
| 1 year | 0.00 | 2.87 [2.39, 3.46] | 8.2e-29 | 187 |
Index endpoint: KELA_DIAB_INSUL – Diabetes, insuline treatment (Kela reimbursement)
GWS hits: 87
before Diabetes, insuline treatment (Kela reimbursement)
after Diabetes, insuline treatment (Kela reimbursement)
Loading survival analyses plot
Loading survival analyses table